Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 190

    1.

    Itraconazole versus fluconazole for antifungal prophylaxis.

    Mossad SB.

    Ann Intern Med. 2004 Apr 6;140(7):580-1; author reply 581-2. No abstract available. PMID: 15068993 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Itraconazole versus fluconazole for antifungal prophylaxis.

    Powers JH, Higgins KM.

    Ann Intern Med. 2004 Apr 6;140(7):580; author reply 581-2. No abstract available. PMID: 15068992 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Itraconazole versus fluconazole for antifungal prophylaxis.

    Karthaus M, Cornely OA, Ullmann AJ.

    Ann Intern Med. 2004 Apr 6;140(7):579-80; author reply 581-2. No abstract available. PMID: 15068991 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation.

    Marr KA.

    Clin Infect Dis. 2004 Oct 15;39 Suppl 4:S170-5.PMID: 15546113 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

    Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.

    Ann Intern Med. 2003 May 6;138(9):705-13.PMID: 12729424 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Role of new antifungal agents in prophylaxis of mycoses in high risk patients.

    van Burik JA.

    Curr Opin Infect Dis. 2005 Dec;18(6):479-83. Review.PMID: 16258319 [PubMed - indexed for MEDLINE]Related articles

    7.

    Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.

    Mossad SB, Avery RK, Bolwell BJ.

    Clin Infect Dis. 2003 Jun 1;36(11):1503-4; author reply 1504. No abstract available. PMID: 12766853 [PubMed - indexed for MEDLINE]Related articles

    8.

    Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.

    Vardakas KZ, Michalopoulos A, Falagas ME.

    Br J Haematol. 2005 Oct;131(1):22-8. Erratum in: Br J Haematol. 2006 Mar;132(5):665. PMID: 16173959 [PubMed - indexed for MEDLINE]Related articles

    9.

    A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.

    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.

    Bone Marrow Transplant. 2006 Jul;38(2):127-34. Epub 2006 Jun 5.PMID: 16751782 [PubMed - indexed for MEDLINE]Related articles

    10.

    Choosing a study population for the evaluation of antifungal prophylaxis.

    Cornely OA, Ullmann AJ, Karthaus M.

    Clin Infect Dis. 2005 Jun 1;40(11):1699; author reply 1699-701. No abstract available. PMID: 15889374 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.

    Glasmacher A, Prentice AG.

    J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i23-i32. Review.PMID: 16120631 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.

    Prentice AG, Glasmacher A, Djulbegovic B.

    Br J Haematol. 2006 Mar;132(5):656-8; author reply 658-9. No abstract available. PMID: 16445845 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.

    Tamura K, Drew R.

    Drugs Today (Barc). 2008 Jul;44(7):515-30. Review.PMID: 18806902 [PubMed - indexed for MEDLINE]Related articles

    14.

    Posaconazole prophylaxis in hematologic cancer.

    van Nieuwkoop C, van Dissel JT.

    N Engl J Med. 2007 May 24;356(21):2215; author reply 2215-8. No abstract available. PMID: 17526089 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Antifungal prophylaxis in allogenic hematopoietic stem-cell transplant recipients]

    Kanakura Y, Winston DJ.

    Jpn J Antibiot. 2004 Aug;57(4):421-4. Japanese. No abstract available. PMID: 15535043 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.

    de Vries R, Daenen S, Tolley K, Glasmacher A, Prentice A, Howells S, Christopherson H, de Jong-van den Berg LT, Postma MJ.

    Pharmacoeconomics. 2008;26(1):75-90.PMID: 18088160 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antifungal prophylaxis in hematopoietic stem cell transplant recipients.

    Marr KA.

    Curr Opin Infect Dis. 2001 Aug;14(4):423-6. Review.PMID: 11964859 [PubMed - indexed for MEDLINE]Related articles

    19.

    [The impact of itraconazole versus fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation]

    Cai CJ, Yi SH, Guo Y, Li MR, Yi HM, Yang Y, Lu MQ, Chen GH.

    Zhonghua Nei Ke Za Zhi. 2007 Nov;46(11):911-3. Chinese. PMID: 18261273 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prophylaxis and aspergillosis--has the principle been proven?

    De Pauw BE, Donnelly JP.

    N Engl J Med. 2007 Jan 25;356(4):409-11. No abstract available. PMID: 17251538 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data